Farglory Life Insurance Co., Ltd. (TPEX:5859)
Taiwan
· Delayed Price · Currency is TWD 15.90
-0.10 (-0.63%)
May 21, 2025, 2:56 PM CST
Farglory Life Insurance Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Premiums & Annuity Revenue | 56,121 | 55,840 | 53,195 | 55,068 | 69,571 | 77,081 | Upgrade
|
| Total Interest & Dividend Income | 20,290 | 19,797 | 18,317 | 19,131 | 19,838 | 16,430 | Upgrade
|
| Gain (Loss) on Sale of Investments | -8,785 | -15,899 | -83.08 | -22,188 | 13,221 | 14,673 | Upgrade
|
| Other Revenue | -1.84 | -10.67 | 76.93 | 87.83 | 64.4 | 34.5 | Upgrade
|
| Total Revenue | 67,623 | 59,727 | 71,505 | 52,098 | 102,694 | 108,218 | Upgrade
|
| Revenue Growth (YoY) | 3.88% | -16.47% | 37.25% | -49.27% | -5.10% | 4.59% | Upgrade
|
| Policy Benefits | 66,851 | 66,351 | 64,037 | 65,903 | 76,871 | 83,458 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 5,224 | 5,163 | 4,519 | 4,600 | 4,860 | 5,339 | Upgrade
|
| Selling, General & Administrative | 2,295 | 2,269 | 2,336 | 2,540 | 2,535 | 2,408 | Upgrade
|
| Provision for Bad Debts | 37.06 | 39.5 | -0.26 | 19.12 | 15.62 | 1.26 | Upgrade
|
| Other Operating Expenses | 269.25 | 273.31 | 104.32 | 100.37 | 146.03 | 180.23 | Upgrade
|
| Total Operating Expenses | 74,676 | 74,095 | 70,996 | 73,162 | 84,428 | 91,386 | Upgrade
|
| Operating Income | -7,052 | -14,368 | 509.27 | -21,063 | 18,266 | 16,832 | Upgrade
|
| Interest Expense | -4.36 | -4.7 | -5.27 | -5.32 | -6.58 | -4.65 | Upgrade
|
| Currency Exchange Gain (Loss) | 12,497 | 19,204 | 1,673 | 27,707 | -10,020 | -12,945 | Upgrade
|
| Other Non Operating Income (Expenses) | 32.75 | 39.67 | 29.52 | 18.45 | 46.45 | 48.37 | Upgrade
|
| EBT Excluding Unusual Items | 5,474 | 4,871 | 2,207 | 6,657 | 8,286 | 3,931 | Upgrade
|
| Pretax Income | 5,474 | 4,871 | 2,207 | 6,657 | 8,286 | 3,931 | Upgrade
|
| Income Tax Expense | -952.97 | -652.06 | 0.24 | 590.2 | 1,821 | 694.36 | Upgrade
|
| Net Income | 6,427 | 5,523 | 2,206 | 6,067 | 6,465 | 3,237 | Upgrade
|
| Net Income to Common | 6,427 | 5,523 | 2,206 | 6,067 | 6,465 | 3,237 | Upgrade
|
| Net Income Growth | 14.86% | 150.33% | -63.63% | -6.16% | 99.72% | 60.53% | Upgrade
|
| Shares Outstanding (Basic) | 1,355 | 1,355 | 1,355 | 1,355 | 1,355 | 1,355 | Upgrade
|
| Shares Outstanding (Diluted) | 1,357 | 1,358 | 1,357 | 1,360 | 1,361 | 1,359 | Upgrade
|
| Shares Change (YoY) | -0.02% | 0.02% | -0.22% | -0.04% | 0.12% | 0.29% | Upgrade
|
| EPS (Basic) | 4.74 | 4.07 | 1.63 | 4.48 | 4.77 | 2.39 | Upgrade
|
| EPS (Diluted) | 4.74 | 4.07 | 1.63 | 4.46 | 4.75 | 2.38 | Upgrade
|
| EPS Growth | 14.95% | 150.03% | -63.53% | -6.02% | 99.23% | 60.50% | Upgrade
|
| Free Cash Flow | 11,512 | 14,749 | 11,815 | 19,034 | 42,360 | 38,436 | Upgrade
|
| Free Cash Flow Per Share | 8.48 | 10.86 | 8.70 | 13.99 | 31.12 | 28.28 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.917 | - | Upgrade
|
| Operating Margin | -10.43% | -24.06% | 0.71% | -40.43% | 17.79% | 15.55% | Upgrade
|
| Profit Margin | 9.50% | 9.25% | 3.09% | 11.64% | 6.30% | 2.99% | Upgrade
|
| Free Cash Flow Margin | 17.02% | 24.70% | 16.52% | 36.54% | 41.25% | 35.52% | Upgrade
|
| EBITDA | -6,735 | -14,045 | 901.91 | -20,665 | 18,662 | 17,202 | Upgrade
|
| EBITDA Margin | -9.96% | -23.52% | 1.26% | -39.67% | 18.17% | 15.90% | Upgrade
|
| D&A For EBITDA | 316.69 | 323.49 | 392.63 | 397.86 | 396.54 | 369.55 | Upgrade
|
| EBIT | -7,052 | -14,368 | 509.27 | -21,063 | 18,266 | 16,832 | Upgrade
|
| EBIT Margin | -10.43% | -24.06% | 0.71% | -40.43% | 17.79% | 15.55% | Upgrade
|
| Effective Tax Rate | - | - | 0.01% | 8.87% | 21.98% | 17.66% | Upgrade
|
| Revenue as Reported | 946.79 | - | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.